DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Aguirre A. de Cubas(Medical University of South Carolina), Miguel A. Peinado(Badalona Serveis Assistencials), María Rosa Bella(Universitat Autònoma de Barcelona), Esmeralda Castelblanco(Universitat de Lleida), Jordi L. Reverter(Universitat Autònoma de Barcelona), Francisco Xavier Maravall(Hospital Universitari Arnau de Vilanova), Ismael Capel(Hospital de Sabadell), Raquel Buj(Penn State Milton S. Hershey Medical Center), Xavier Matías‐Guiu(Universitat de Lleida), Enrique Lerma(Universitat Autònoma de Barcelona), Manel Puig‐Domingo(Universitat Autònoma de Barcelona), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Mireia Jordà(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), María Currás-Freixes(Spanish National Cancer Research Centre), Eva Castellà(Universitat Autònoma de Barcelona), Dı́dac Mauricio(Universitat de Vic - Universitat Central de Catalunya)
Cited by 77
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528